Welcome to Medications.com

Adderall XR News

UK Stocks Decline, Paced by Standard Life, RBS, Barclays - Bloomberg

Vyvanse is a successor to Adderall XR for attention deficit hyperactivity disorder. CRH Plc (CRH ID) fell 15 cents, or 0.8 percent, to 25.93 euros. ...

Posted: Wed Jan 30 06:08:52 -0500 2008

UK Stocks Fall, Led by Royal Bank, Barclays, Standard Life - Bloomberg

Vyvanse is a successor to Adderall XR for attention deficit hyperactivity disorder. Thomas Cook Group Plc (TCG LN), Europe's second-biggest tour operator, ...

Posted: Wed Jan 30 12:38:32 -0500 2008

More carnage for Shire - Guardian Unlimited

"This not only entails converting patients from Adderall XR but also the more significant patient population currently using alternative therapies. ...

Posted: Wed Jan 30 08:15:45 -0500 2008

Shire sales targets 'unrealistic' - Hemscott

He cited concerns over Vyvanse, the group's replacement for its blockbuster treatment for attention deficit hyperactivity disorder (ADHD), Adderall XR, ...

http://www.hemscott.com/news/comm... | Posted: Mon Jan 28 04:24:36 -0500 2008

Property crawls out from the basement - Times Online

... because of worries about its Vyvanse hyperactivity drug, which is designed to replace the block-buster Adderall XR, whose patent expires next year. ...

http://business.timesonline.co.uk... | Posted: Mon Jan 14 19:38:42 -0500 2008

Property crawls out from the basement - Times Online

... because of worries about its Vyvanse hyperactivity drug, which is designed to replace the block-buster Adderall XR, whose patent expires next year. ...

Posted: Mon Jan 14 19:38:42 -0500 2008

ADRs in Focus: European Pharma - Houston Chronicle

About 18 percent of Adderall XR patients are now using Vyvanse, Cacciatore said. Generic versions of Adderall can be sold in April 2009, while Vyvanse is ...

Posted: Tue Jan 08 16:31:30 -0500 2008

Chimerix Appoints Neil Frazer, MB, Ch.B., FRCA, FFPM as Chief ... - Carolina Newswire (press release)

... Clinical Research at Shire Pharmaceuticals where he was responsible for clinical drug development of key programs that included Adderall XR, ...

http://carolinanewswire.com/news/... | Posted: Thu Jan 03 12:11:02 -0500 2008

Chimerix Appoints Neil Frazer, MB, Ch.B., FRCA, FFPM as Chief ... - PR Newswire (press release)

... Clinical Research at Shire Pharmaceuticals where he was responsible for clinical drug development of key programs that included Adderall XR, ...

http://www.prnewswire.com/cgi-bin... | Posted: Thu Jan 03 08:03:03 -0500 2008

Chimerix Appoints Neil Frazer, MB, Ch.B., FRCA, FFPM as Chief ... - PR Newswire (press release)

... Clinical Research at Shire Pharmaceuticals where he was responsible for clinical drug development of key programs that included Adderall XR, ...

Posted: Thu Jan 03 08:03:03 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea